Baxter International Inc at Morgan Stanley Global Healthcare Conference Transcript
Amazing. Thank you, everyone. You've got Patrick on the U.S. Medtech team. I'm obviously delighted today to have Jose Almeida, the CEO of Baxter; and Clare Trachtman, who runs the IR function to join us for what should be a fun chat. Before I get started, we've got the delightful disclosures, Morganfamily.com/researchdisclosures and then also you can reach out to your sales rep if any of you feel -- on and need to do so.
Questions & Answers
Thank you so much for joining us both and Joe, maybe if we could start with sort of a bigger picture question for Baxter. Innovation and driving growth up to that mid-single-digit range is kind of a key focus. How do you feel the pipeline of innovation is looking and what are you most excited about?
I think we look at the growth story for Baxter in 3 different vectors. The first vector is acceleration of commercial execution. So going to areas of health
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |